Geode Capital Management LLC grew its stake in DocGo Inc. (NASDAQ:DCGO – Free Report) by 1.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,252,516 shares of the company’s stock after buying an additional 39,016 shares during the quarter. Geode Capital Management LLC’s holdings in DocGo were worth $7,480,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the stock. nVerses Capital LLC raised its position in DocGo by 151.5% during the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after acquiring an additional 5,000 shares in the last quarter. Marathon Capital Management increased its holdings in shares of DocGo by 2.3% during the 2nd quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after purchasing an additional 6,285 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of DocGo by 31.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after purchasing an additional 9,696 shares during the period. Centiva Capital LP purchased a new stake in DocGo during the third quarter worth $43,000. Finally, Victory Capital Management Inc. grew its position in DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after buying an additional 14,191 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.
Insiders Place Their Bets
In other news, General Counsel Ely D. Tendler sold 23,088 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.70% of the stock is currently owned by company insiders.
DocGo Price Performance
Analysts Set New Price Targets
Separately, Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 price objective on shares of DocGo in a research report on Friday, September 20th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $6.10.
Get Our Latest Research Report on DCGO
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Articles
- Five stocks we like better than DocGo
- The Basics of Support and Resistance
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Basic Materials Stocks Investing
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.